inositol pentaphosphate (inositol pentakisphosphate)

Subscribe to Selected New Research on inositol pentaphosphate

5 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to cpd without isomeric designation

Also Known As:

inositol pentakisphosphate; (D)-isomer, specified as 1,2,4,5,6 of inositol pentaphosphate; InsP5; inositol pentis(dihydrogen phosphate); myo-inositol 1,3,4,5,6-pentakisphosphate; myo-inositol pentakis(dihydrogen phosphate)

Bio-Agent Context: Research Results

Organic Chemicals: 40

Alcohols: 309

Sugar Alcohols: 40

Inositol: 1541

Inositol Phosphates: 129

inositol pentaphosphate: 5

Carbohydrates: 2949

Sugar Alcohols: 40

Inositol: 1541

Inositol Phosphates: 129

inositol pentaphosphate: 5

Sugar Phosphates: 11

Inositol Phosphates: 129

inositol pentaphosphate: 5

Related Diseases

1.	Shock 09/01/1995 - "The biochemical differences that distinguished the heat-shocked from the non-heat-shocked chicken cells were: (1) a decrease in intensity of the low and wide (300 Hz) resonance that underlies the high resolution signals and which arises from the partially mobile membrane phospholipids, suggesting that membrane fluidity was decreased during the induction of thermotolerance; and (2) a time-dependent leftward shift of the peak representing the 4,6P of inositol pentaphosphate together with a broadening of all of the 31P peaks during heat-shock and heat challenge, which persisted after return to the control temperature" Order ALL the reference details at left...
2.	Neuroblastoma 05/15/1991 - "The potential Ca2(+)-releasing activity of the inositol tetrakisphosphates Ins(1,3,4,6)P4 and DL-Ins(1,4,5,6)P4 and the inositol pentakisphosphate Ins(1,3,4,5,6)P5 and their effect on Ins(1,4,5)P3- and DL-Ins (1,3,4,5)P4-mediated Ca2+ release were examined in permeabilized SH-SY5Y human neuroblastoma cells" Order ALL the reference details at left...
3.	Inflammation 05/27/1994 - "InsP5 and InsS6 also inhibited inflammation in these models, although higher doses were required for InsS6" Order ALL the reference details at left...
4.	Cataract (Cataracts) 06/01/2008 - "Weighted least square regression for lens opacity revealed that intakes of ascorbic acid, folic acid and inositol pentaphosphate explained 59.7% of the total variation (p<0.01)" Order ALL the reference details at left...
5.	Bacterial Infections (Bacterial Infection) 01/01/2001 - "Furthermore, bacterial infection of intestinal cells resulted in a marked increase in Ins(1,4,5,6)P4, a consumption of InsP5 and the activation of phospholipase C" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Phospholipids
2.	Type C Phospholipases
3.	Inositol (Myoinositol)
4.	Folic Acid (Vitamin M)
5.	Ascorbic Acid (Vitamin C)
6.	inositol-1,3,4,5,6-pentakisphosphate

Best Treatments:
Research Summary Report
on Shock

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1192 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>